OMNIOX INC
Pioneering oxygen-based therapies that restore health
San Francisco, United States · Founded 2015 · $5.8M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- omniox.com
- Total Funding
- $5.8M
- Last Round
- $5.8M Series DJun 2014
- Rounds
- 4
About
Omniox is an IND-stage biotechnology company developing the H-NOX protein platform into first-in-class OMX oxygen delivery therapeutics. The company's pipeline targets diseases where tissue hypoxia drives pathology, including oncology, cardiovascular conditions, stroke, trauma, and sickle cell disease. Founded on technology from UC Berkeley, Omniox has received grants from the National Cancer Institute, National Institute of Neurological Disorders and Stroke, and the Wellcome Trust.
Summary
OMNIOX INC is a Biotech company based in San Francisco, United States, founded in 2015. It has raised $5.8M in total across 4 rounds, most recently a $5.8M Series D round in Jun 2014. Investors include Acadia Woods Partners, Wavemaker 360 Health and Wellcome.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2020
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company

Specialty pharmaceutical company